José Trigo

10.6k citations
164 papers · 5.9k · 1 hit paper · h-index 39

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 1%
    • Lung Cancer Research Studies
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Research Studies 18
    • Cancer Immunotherapy and Biomarkers 12
    • Colorectal Cancer Treatments and Studies 11
    • Lung Cancer Treatments and Mutations 34
    • Lung Cancer Diagnosis and Treatment 9

José Trigo

159 papers receiving 5.8k citations

José Trigo's Hit Papers

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy 2007 · 739 citations
7390+6+12Years since publication200400600

Peers

José Trigo
Comparison fields: 5 of 130
  • Otorhinolaryngology 759
  • Oncology 2.1k
  • Pharmacology 1.1k
  • Toxicology 162
  • Pulmonary and Respiratory Medicine 1.2k
Replace D Müller with:
D Müller Germany
Jin Ho Kim South Korea
Clelia Madeddu Italy
Maryam B. Lustberg United States
Willem Boogerd Netherlands
Jacqueline P. Williams United States
Carl Pinsky Canada
Isabelle M. Germano United States
Suh‐Hang Hank Juo Taiwan
David Gillatt United Kingdom
José Trigo relative to D Müller Germany D Müller's profile →
Citations per field
00.5×10×12.5×
D Müller · 1×
Citations per year

Countries citing papers authored by José Trigo

Since Specialization
Citations

This map shows the geographic impact of José Trigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Trigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Trigo more than expected).

Fields of papers citing papers by José Trigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Trigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Trigo. The network helps show where José Trigo may publish in the future.

Co-authors

The 25 scholars most cited alongside José Trigo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with José Trigo Line = papers co-authored together José Trigo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
Hit paper breakdown →
2007739
2 2002416
3 2005373
4 2014237
5 2008183
6 2017183
7 2009172
8 2005156
9 2018128
10 2021123
11 2015123
12 2010113
13 199998
14 201296
15
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
199990
16 200487
17 201884
18 202170
19 199967
20 200766

About José Trigo

José Trigo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience, having authored 164 papers that have together received 5.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (18 papers), Head and Neck Cancer Studies (18 papers), Cannabis and Cannabinoid Research (15 papers), Neurotransmitter Receptor Influence on Behavior (15 papers), Cancer Immunotherapy and Biomarkers (12 papers), Colorectal Cancer Treatments and Studies (11 papers) and Lung Cancer Diagnosis and Treatment (9 papers). The work is most often cited by research in Otorhinolaryngology (759 citations), Oncology (2.1k citations), Pharmacology (1.1k citations), Toxicology (162 citations) and Pulmonary and Respiratory Medicine (1.2k citations). José Trigo has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Ricardo Hitt, Nadia Amellal, Rafaël Maldonado, José Baselga, Patricia Robledo, P. Koralewski, Eduardo Díaz‐Rubio, Frédéric Rolland, Rainald Knecht and Bernard Le Foll. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Translational Oncology, Journal of Thoracic Oncology, Annals of Oncology and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact